Lung Cancer (NSCLC) Clinical Trials
2 recruiting trials for Lung Cancer (NSCLC). Eligibility criteria explained in plain English.
2
Total Trials
2
Recruiting Now
0
Phase 3 Trials
2
Sponsors
Recruiting Trials
RECRUITINGPhase 1NCT07127874
A Study of PHN-012 in Patients With Advanced Solid Tumors
This first-in-human study will evaluate safety, tolerability, anti-tumor activity, immunogenicity, pharmacokinetics and pharmacodynamics of PHN-012, a novel antibody-drug...
Sponsor: Pheon TherapeuticsEnrolling: 16513 locations
RECRUITINGNCT06800586
Tumors and Respiratory System Diseases Due to Air Pollution: New Biomarkers of Exposure and Effects
This study aims to examine the exposure to atmospheric pollutants in a group of non-smoking patients suffering from lung cancer, chronic obstructive pulmonary disease (COPD), and...
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di BolognaEnrolling: 3003 locations